The occurrence of multidrug-resistant Mycobacterium tuberculosis from suspected patients of tuberculosis in Ilam, Iran

BACKGROUND AND OBJECTIVESMultidrug-resistant Mycobacterium tuberculosis (MDR-TB) is one of the leading causes of death in the world. The resource constraints make it difficult to diagnose and monitor the cases of MDR-TB. GeneXpert is a recognized tool used to diagnose the patients of pulmonary tuberculosis in clinical settings across the globe.MATERIALS AND METHODSA hospital-based cross-sectional study was conducted among ۶۱ tuberculosis suspected patients from ۲۱ March to February ۲۰۲۲. Laboratory examination was processed usingXpert-MTB/RIF assay.RESULTS AND DISCUSSIONIn this study, the prevalence of Mycobacterium tuberculosis was ۶ (۱۰.۱%), and there was no case of rifampicin-resistant/multidrug-resistant Mycobacterium tuberculosis among the ۶ confirmed cases of Mycobacterium tuberculosis.CONCLUSIONDespite implementation of national and international TB control strategies, TB still remains one of the major public health problems. Our data suggests that the prevalence of drug resistant TB remains low in Ilam, and Xpert MTB/RIF assay appears to be an accurate, simple, and useful technique for detecting MTB, especially in respiratory specimens.

کلیدواژه ها:

Xpert-MTB/RIF assay ، Mycobacterium tuberculosis ، tuberculosis